BioSpace News Archive

Business

AbbVie, Anima Strike mRNA Deal Worth Up to $582M

Tuesday, AbbVie partnered with Anima Biotech to discover and develop mRNA modulators in a collaboration of up to $582 million. The partnership will focus on three oncology and immunology targets.

January 10, 2023
·
2 min read
·
Tristan Manalac
Deals

JPM Day 2: Highlights

Stay on top of what’s happening at JPM. BioSpace is covering all the key announcements all week.

January 10, 2023
·
6 min read
·
BioSpace Staff
Business

Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM

In a presentation led by Robert J. Bradway, Amgen chairman and chief executive officer, the company covered recent acquisitions, Repatha and Lumakras updates, biosimilars and its broader financial outlook.

January 10, 2023
·
2 min read
·
Lisa Munger
Business

Despite Slowdown in COVID, Pfizer Promises Growth

Pfizer forecasts stable growth in the coming years, driven by a strong product push to cushion its non-COVID business and exclusivity losses.

January 10, 2023
·
2 min read
·
Tristan Manalac
Merck Highlights Growth Strategy at J.P. Morgan

The drugmaker’s presentation highlights its strong revenue growth, dominant vaccine business and expanding oncology portfolio.

January 10, 2023
·
3 min read
·
Alex Keown
Sponsored: Complete Genomics Touts Sequencing Platform, Product Launches at Biotech Showcase

Complete Genomics showcased its innovative sequencing capacity at the Biotech Showcase 2023, one of the year’s most important investor conferences.

January 10, 2023
·
4 min read
·
Editorial Staff
Santhera enters into CHF 5 million share exchange agreement

Santhera Pharmaceuticals announces that through a share exchange it will receive the equivalent of CHF 5 million Idorsia shares whichSanthera is free to sell at its own discretion in support of its short-term financial needs.

January 10, 2023
·
3 min read
Valbiotis Announces Its Roadmap for 2023: a Pivotal Year in the Execution of Its Clinical, Industrial and Commercial Strategy

Valbiotis, a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces its roadmap for 2023.

January 10, 2023
·
7 min read
European Association of Cardiovascular Imaging (EACVI) Collaborates With Surgical Science to Pilot the First Online Transesophagel Echo (TOE) Testing

The EACVI and Surgical Science have joined forces to create a unique TOE online simulator, aiming to evaluate TOE knowledge and performance level among young cardiologists and assess the need for simulation training for this purpose.

January 10, 2023
·
3 min read
Business

SIFI Announces License Agreement With Avanzanite Bioscience for Akantior®

SIFI announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute AKANTIOR® in 26 Countries within the European Economic Area and Switzerland.

January 10, 2023
·
5 min read